UMB 425 is being called a breakthrough in the development of therapeutics to treat chronic pain, acts on two different opioid receptors with diminished tolerance over time and no obvious toxic effects.
A team of researchers led by Andrew Coop, PhD, professor and chair of the Department of Pharmaceutical Sciences (PSC) at the University of Maryland School of Pharmacy (UMSOP), has developed a new opioid drug that shows great potential to advance treatment and improve quality of life for individuals living with chronic pain. Spotlighted in a recent issue of ACS Chemical Neuroscience, the compound, known as UMB 425, is as strong as morphine, but displays diminished tolerance over time with no obvious toxic effects.
“UMB 425 is a breakthrough in the development of therapeutics to treat chronic pain,” says Coop. “Unlike other drugs developed to act on only one biological target, UMB 425 acts on two different opioid receptors in the body. When activated at the same time, these receptors work together to provide pain relief and slow the body’s development of tolerance to the drug. This diminished tolerance allows a lower dose of the opioid to be administered for a longer time period, while still achieving the same level of pain relief.”
For individuals living with chronic pain, either as a result of injury or disease such as arthritis, opioids are the standard treatment. But as the dosage increases to offset the body’s tolerance to their effects, opioids cause a number of adverse effects, including constipation, nausea, drowsiness, and dizziness. The unique dual-profile of UMB 425 – made possible through Coop’s collaborations with Alexander MacKerell, PhD, professor in PSC and director of the School’s Computer Aided Drug Design Center, and Maureen Kane, PhD, assistant professor in PSC and co-director of the School’s Mass Spectrometry Facility – provides both pain relief as well as diminished tolerance in one drug.
“Historically, medicinal chemists have developed drugs aimed at only one biological target,” says Coop. “However, two drugs administered together have the potential to metabolize differently in different individuals, as well as affect patients’ adherence to both drugs. A single compound that is able to provide both pain relief and diminished tolerance has the advantage of a defined ratio that we can optimize to ensure patients receive the maximum pain relief, while experiencing minimum adverse effects.”
Coop and his team conducted several in vitro and in vivo studies to determine the drug’s effectiveness in alleviating pain and diminishing tolerance over time. If future research and clinical trials are successful, UMB 425 could have a significant impact on the treatment and quality of life for individuals living with chronic pain.
“The clinical implication of this research has the potential to be tremendous,” says Mary Lynn McPherson, PharmD, BCPS, CPE, professor and vice chair for academic affairs in the Department of Pharmacy Practice and Science, and an international authority in the fields of pain management and palliative care. “If clinicians can prescribe lower doses of opioids, they will not have to raise a patient’s dose because of tolerance to the analgesic effects. Using lower doses will result in less severe adverse effects for the patient, both short-term effects such as nausea and constipation, as well as long-term adverse effects on the endocrine and immunologic systems. This would be a highly significant advance in pain management.”
The Latest Bing News on:
Chronic Pain
- Almost 30% of children and adolescents experience pain in muscles, bones or ligaments, study showson May 8, 2024 at 1:44 pm
Some 27% of Brazilian children and adolescents suffer from musculoskeletal pain of unspecified cause, according to a study reported in the Brazilian Journal of Physical Therapy. The problem is ...
- What Americans would give up to be pain-freeon May 8, 2024 at 12:19 pm
Three in 10 Americans have had zero days completely pain-free in the last month and 28% feel some kind of pain every single day, according to new research. A survey of 2,000 Americans revealed that ...
- 3 exercises everyone does that makes back pain WORSE, says experton May 8, 2024 at 9:12 am
Dr Arthur Jenkins, a spine surgeon, warned people away from bending backHe warned this could cause a disk to herniate, or ruptureREAD MORE: One in five Americans live with chronic pain, study ...
- Tele-mentoring program shows promise in addressing opioid reliance for chronic pain managementon May 7, 2024 at 11:07 pm
More Americans suffer from chronic pain than diabetes, heart disease, and cancer combined. Yet, a shortage of pain medicine specialists persists, causing many pain sufferers to seek care in primary ...
- Chronic Pain Help At Rosedale Acupuncture & Wellnesson May 7, 2024 at 12:17 pm
Do you have long-term, chronic pain…maybe you feel older than you are? Dr. Lucas Brown, DAOM, LAc with Rosedale Acupuncture and Wellness spoke with Studio 512 about offering help to people who are ...
- Woman who suffers with chronic pain wants to challenge the stigma that comes with having chronic pain at a young ageon May 7, 2024 at 7:13 am
Abigail Stone has suffered with chronic pain for six years. She wants to reframe the profile of what people perceive chronic pain sufferers to be.
- Childhood chronic pain: ‘There’s a self-hatred that stems from chronic pain and illness, as much as I know it’s not my fault’on May 6, 2024 at 5:30 pm
How can adolescents fit in with their peers — who are typically heading to nightclubs after college lectures, crashing on couches when the party wraps up and balancing weekend work in a pub — when ...
- Best Tools For Managing Chronic Painon May 2, 2024 at 5:18 am
In 2019, more than 20% of U.S. adults experienced pain almost daily for three consecutive months, according to the Centers for Disease Control and Prevention (CDC) [1] Summary Health Statistics.
- A Predictive Healthcare Visionary Is Optimistic About Solving America’s Opioid Addiction And Chronic Pain Epidemicon April 26, 2024 at 2:20 pm
Studies found that Chronic pain is more prevalent and costly than cancer, diabetes, and heart disease combined, and its rates are rising even as other chronic ...
- Scientists Make Breakthrough in Chronic Pain Treatmenton April 26, 2024 at 7:53 am
Scientists have developed tiny robotic nerve "cuffs" to diagnose and treat neurological disorders. The flexible devices offer a safer, minimally invasive alternative to today's diagnostics and could ...
The Latest Google Headlines on:
Chronic Pain
[google_news title=”” keyword=”Chronic Pain” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
UMB 425
- UMB Financialon May 5, 2024 at 5:00 pm
UMB Financial Corporation is a financial services company headquartered in Kansas City, Missouri. UMB offers commercial banking, which includes comprehensive deposit, lending and investment ...
- UMBF UMB Financial Corporationon May 3, 2024 at 9:00 am
UMB Financial Corporation operates as the bank holding company that provides banking services and asset servicing in the United States and internationally. The Commercial Banking segment provides ...
- UMB Financial Corporation (UMBF)on May 2, 2024 at 5:00 pm
UMB Financial Corporation (NASDAQ:UMBF) Q1 2024 Earnings Call Transcript May 1, 2024 UMB Financial Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...
- UMB Financial to acquire Heartland Financial for $2 billionon April 29, 2024 at 2:15 pm
UMB Financial in Kansas City, Missouri, plans to acquire Heartland Financial USA in Denver and tap into Heartland's low-cost deposit base to support its growth strategy. The pending $2 billion ...
- UMB Financial to Buy Rival Bank Heartland in $2 Billion Dealon April 29, 2024 at 8:57 am
UMB Financial Corp. agreed to acquire rival Heartland Financial USA Inc. for about $2 billion in an all-stock transaction poised to be the year’s largest US regional-bank deal. Under the terms ...
- UMB Financial Q1 Net Income Rises; UMB To Acquire Heartland Financialon April 29, 2024 at 5:03 am
(RTTNews) - UMB Financial (UMBF), a financial services company, reported first quarter net income of $110.3 million, or $2.25 per share, compared to $92.4 million, or $1.90 per share, in the first ...
- UMB: Q1 Earnings Snapshoton April 29, 2024 at 4:39 am
KANSAS CITY, Mo. — KANSAS CITY, Mo. — UMB Financial Corp. (UMBF) on Monday reported net income of $110.3 million in its first quarter. The Kansas City, Missouri-based bank said it had earnings ...
- UMB Announces Agreement to Acquire Heartland Financialon April 29, 2024 at 12:31 am
Largest acquisition in UMB history will increase total assets by more than 40% and significantly expand geographic footprint UMB investment community call today, Monday, April 29, at 7:30 a.m. (CT ...
- UMB reaches deal on $2B acquisition of Denver-based bank, biggest in its historyon April 28, 2024 at 5:00 pm
UMB Financial Corp., which has a large presence in the St. Louis area, will acquire Heartland Financial USA Inc. in all-stock transaction valued at about $2 billion. UMB Financial Corp. (Nasdaq ...
- UMB Financial in Talks to Acquire Rival Bank Heartlandon April 26, 2024 at 1:01 pm
UMB Financial Corp. is in talks to acquire rival Heartland Financial USA Inc., people with knowledge of the matter said, in what would be the biggest US regional bank merger this year. A deal ...
The Latest Google Headlines on:
UMB 425
[google_news title=”” keyword=”UMB 425″ num_posts=”10″ blurb_length=”0″ show_thumb=”left”]